氨基糖苷类药物的多功能性及其未来前景。
Versatility of aminoglycosides and prospects for their future.
作者信息
Vakulenko Sergei B, Mobashery Shahriar
机构信息
Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA.
出版信息
Clin Microbiol Rev. 2003 Jul;16(3):430-50. doi: 10.1128/CMR.16.3.430-450.2003.
Abstract
Aminoglycoside antibiotics have had a major impact on our ability to treat bacterial infections for the past half century. Whereas the interest in these versatile antibiotics continues to be high, their clinical utility has been compromised by widespread instances of resistance. The multitude of mechanisms of resistance is disconcerting but also illuminates how nature can manifest resistance when bacteria are confronted by antibiotics. This article reviews the most recent knowledge about the mechanisms of aminoglycoside action and the mechanisms of resistance to these antibiotics.
摘要
在过去的半个世纪里，氨基糖苷类抗生素对我们治疗细菌感染的能力产生了重大影响。尽管人们对这些多功能抗生素的兴趣依然浓厚，但它们的临床效用却因广泛存在的耐药情况而大打折扣。众多的耐药机制令人担忧，但也揭示了细菌在面对抗生素时，自然界是如何表现出耐药性的。本文综述了关于氨基糖苷类抗生素作用机制以及对这些抗生素耐药机制的最新知识。
相似文献
1
Versatility of aminoglycosides and prospects for their future.
Clin Microbiol Rev. 2003 Jul;16(3):430-50. doi: 10.1128/CMR.16.3.430-450.2003.
2
Aminoglycoside-modifying enzymes.
Curr Opin Microbiol. 1999 Oct;2(5):499-503. doi: 10.1016/s1369-5274(99)00007-7.
3
Studies of enzymes that cause resistance to aminoglycosides antibiotics.
Methods Mol Med. 2008;142:261-71. doi: 10.1007/978-1-59745-246-5_20.
4
Bacterial resistance to aminoglycoside antibiotics.
Trends Microbiol. 1997 Jun;5(6):234-40. doi: 10.1016/S0966-842X(97)01033-0.
5
Modification of aminoglycoside antibiotics by clinical isolates of Streptococcus faecalis.
J Antibiot (Tokyo). 1981 Feb;34(2):224-30. doi: 10.7164/antibiotics.34.224.
6
Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition.
Drug Resist Updat. 2001 Apr;4(2):106-17. doi: 10.1054/drup.2001.0197.
7
[Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
Antibiot Khimioter. 2004;49(5):11-23.
8
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.
Microbiol Rev. 1993 Mar;57(1):138-63. doi: 10.1128/mr.57.1.138-163.1993.
9
[Future development of antibiotics. 3. Aminoglycoside antibiotics].
Nihon Rinsho. 1984 Mar;42(3):540-6.
10
[Types of aminoglycoside-inactivating enzymes of opportunistic strains of Enterobacteriaceae].
Antibiot Khimioter. 1991 Jan;36(1):16-20.
引用本文的文献
1
Total Synthesis of Kanamycins.
Chemistry. 2025 Jul 8;31(38):e202500685. doi: 10.1002/chem.202500685. Epub 2025 Apr 26.
2
A review of antibiotic safety in pregnancy-2025 update.
Pharmacotherapy. 2025 Apr;45(4):227-237. doi: 10.1002/phar.70010. Epub 2025 Mar 19.
3
Exploring molecular mechanisms of drug resistance in bacteria and progressions in CRISPR/Cas9-based genome expurgation solutions.
Glob Med Genet. 2025 Feb 16;12(2):100042. doi: 10.1016/j.gmg.2025.100042. eCollection 2025 Jun.
4
The Global Challenge of : Antimicrobial Resistance and Emerging Intervention Strategies.
Trop Med Infect Dis. 2025 Jan 16;10(1):25. doi: 10.3390/tropicalmed10010025.
5
A brief insight into species - a growing threat to public health.
Front Antibiot. 2023 Dec 5;2:1276982. doi: 10.3389/frabi.2023.1276982. eCollection 2023.
6
APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus.
ChemMedChem. 2025 Apr 14;20(8):e202400842. doi: 10.1002/cmdc.202400842. Epub 2025 Jan 26.
7
Phenotypic Differentiation Within the ' Aminoglycoside Resistance Gene Family Suggests a Novel Subtype IV of Contemporary Clinical Relevance.
Antibiotics (Basel). 2024 Dec 8;13(12):1196. doi: 10.3390/antibiotics13121196.
8
Prevalence and virulence of Vibrio parahaemolyticus isolated from clinical and environmental samples in Huzhou, China.
BMC Genomics. 2024 Dec 5;25(1):1187. doi: 10.1186/s12864-024-11106-3.
9
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
Drugs. 2025 Jan;85(1):21-40. doi: 10.1007/s40265-024-02104-6. Epub 2024 Nov 28.
10
The point mutation A1387G in the 16S rRNA gene confers aminoglycoside resistance in and .
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0083324. doi: 10.1128/aac.00833-24. Epub 2024 Oct 15.
本文引用的文献
1
Vancomycin resistance in staphylococci.
Drug Resist Updat. 1998;1(2):135-50. doi: 10.1016/s1368-7646(98)80029-0.
2
Protein synthesis at atomic resolution: mechanistics of translation in the light of highly resolved structures for the ribosome.
Curr Protein Pept Sci. 2002 Feb;3(1):1-53. doi: 10.2174/1389203023380846.
3
New (and not so new) antibacterial targets - from where and when will the novel drugs come?
Curr Opin Pharmacol. 2002 Oct;2(5):513-22. doi: 10.1016/s1471-4892(02)00197-2.
4
R391: a conjugative integrating mosaic comprised of phage, plasmid, and transposon elements.
J Bacteriol. 2002 Sep;184(18):5158-69. doi: 10.1128/JB.184.18.5158-5169.2002.
5
Protein kinase inhibitors and antibiotic resistance.
Pharmacol Ther. 2002 Feb-Mar;93(2-3):283-92. doi: 10.1016/s0163-7258(02)00197-3.
6
Occurrence of antibiotic resistance gene cassettes aac(6')-Ib, dfrA5, dfrA12, and ereA2 in class I integrons in non-O1, non-O139 Vibrio cholerae strains in India.
Antimicrob Agents Chemother. 2002 Sep;46(9):2948-55. doi: 10.1128/AAC.46.9.2948-2955.2002.
7
Class 1 integron containing a new gene cassette, aadA10, associated with Tn1404 from R151.
Antimicrob Agents Chemother. 2002 Aug;46(8):2400-8. doi: 10.1128/AAC.46.8.2400-2408.2002.
8
Detection and characterization of class 1 integrons in enterohemorrhagic Escherichia coli.
Microb Drug Resist. 2002 Summer;8(2):85-91. doi: 10.1089/107662902760190626.
9
Genomic and functional analyses of SXT, an integrating antibiotic resistance gene transfer element derived from Vibrio cholerae.
J Bacteriol. 2002 Aug;184(15):4259-69. doi: 10.1128/JB.184.15.4259-4269.2002.
10
Genomics in anti-infective drug discovery--getting to endgame.
Curr Pharm Des. 2002;8(13):1099-118. doi: 10.2174/1381612023394845.
Zotero 插件